KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes...<< Prices as on Dec 04, 2024 - 2:15PM >>  ABB India 7646.8  [ 1.43% ]  ACC 2246.4  [ -1.97% ]  Ambuja Cements 562  [ -0.83% ]  Asian Paints Ltd. 2461  [ -0.32% ]  Axis Bank Ltd. 1158.1  [ -0.17% ]  Bajaj Auto 9028.05  [ -1.45% ]  Bank of Baroda 255.8  [ 0.51% ]  Bharti Airtel 1589.1  [ -1.89% ]  Bharat Heavy Ele 251  [ -0.53% ]  Bharat Petroleum 294.8  [ 0.22% ]  Britannia Ind. 4896.2  [ -0.27% ]  Cipla 1507.15  [ -1.78% ]  Coal India 419.65  [ -0.57% ]  Colgate Palm. 2858  [ -1.32% ]  Dabur India 521.2  [ -0.31% ]  DLF Ltd. 842.8  [ -0.48% ]  Dr. Reddy's Labs 1213.9  [ -0.91% ]  GAIL (India) 204.4  [ 2.20% ]  Grasim Inds. 2704.3  [ -0.36% ]  HCL Technologies 1884  [ -0.27% ]  HDFC 2729.95  [ -0.62% ]  HDFC Bank 1855  [ 1.54% ]  Hero MotoCorp 4633  [ -1.37% ]  Hindustan Unilever L 2481.5  [ 0.01% ]  Hindalco Indus. 661.25  [ -0.88% ]  ICICI Bank 1310.35  [ 0.23% ]  IDFC L 108  [ -1.77% ]  Indian Hotels Co 811.25  [ 0.61% ]  IndusInd Bank 994.2  [ -0.42% ]  Infosys L 1885  [ -0.34% ]  ITC Ltd. 471.5  [ -0.17% ]  Jindal St & Pwr 922.75  [ -0.29% ]  Kotak Mahindra Bank 1755.75  [ 0.36% ]  L&T 3787  [ 0.10% ]  Lupin Ltd. 2083.7  [ 0.11% ]  Mahi. & Mahi 3024  [ -0.07% ]  Maruti Suzuki India 11158.45  [ -1.06% ]  MTNL 49.4  [ 0.53% ]  Nestle India 2250.15  [ -0.46% ]  NIIT Ltd. 221  [ -0.50% ]  NMDC Ltd. 233.15  [ -1.02% ]  NTPC 370.95  [ 0.94% ]  ONGC 261.8  [ -0.17% ]  Punj. NationlBak 108.4  [ 0.42% ]  Power Grid Corpo 323.9  [ -1.77% ]  Reliance Inds. 1309  [ -1.08% ]  SBI 853  [ -0.11% ]  Vedanta 465.05  [ -0.70% ]  Shipping Corpn. 237.35  [ -0.15% ]  Sun Pharma. 1788.45  [ -0.56% ]  Tata Chemicals 1127  [ -0.80% ]  Tata Consumer Produc 952.9  [ -0.13% ]  Tata Motors 786.3  [ -1.85% ]  Tata Steel 144.7  [ -1.26% ]  Tata Power Co. 425.15  [ -0.85% ]  Tata Consultancy 4347.55  [ 1.07% ]  Tech Mahindra 1750  [ 0.03% ]  UltraTech Cement 11812.95  [ -0.31% ]  United Spirits 1525.7  [ -1.09% ]  Wipro 293.25  [ 0.53% ]  Zee Entertainment En 137.7  [ -0.29% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

AKUMS DRUGS & PHARMACEUTICALS LTD.

04 December 2024 | 02:04

Industry >> Pharmaceuticals

Select Another Company

ISIN No INE09XN01023 BSE Code / NSE Code 544222 / AKUMS Book Value (Rs.) 45.26 Face Value 2.00
Bookclosure 52Week High 1176 EPS 0.00 P/E 0.00
Market Cap. 9686.03 Cr. 52Week Low 530 P/BV / Div Yield (%) 13.60 / 0.00 Market Lot 1.00
Security Type Other

History of Company

The company history sections lists out major chronological events that happened to the company.
Our Company was incorporated as a public limited company under the Companies Act, 1956 as `Akums Drugs and Pharmaceuticals Limited', pursuant to a certificate of incorporation dated April 19, 2004 issued by the RoC. Our Company received a certificate for commencement of business issued by the RoC dated May 13, 2004.

Major Events and Milestones:
2004
-Incorporation of the Company
-Established first plant for oral dosage commissioned at 19, 20, 21, sector 6A, Haridwar, Uttarakhand

2007
-Established dedicated manufacturing site for oral liquid dosage at 22, Sector 6A, Sidcul, Haridwar, Uttarakhand and sterile products at 2,3,4,5, Sector 6B, SIDCUL, Haridwar, Uttarakhand

2009
-Incorporated Maxcure Nutravedics Limited to venture into nutraceuticals

2010
-Dedicated a facility for hormones at 48, Sector 6A, SIDCUL, Haridwar, Uttarakhand
-Dedicated a facility for cosmetics and dermatology at 47, Sector 6A, SIDCUL, Haridwar, Uttarakhand
-Incorporated Akumentis Healthcare Limited to venture into branded formulations

2011
-Innovated bi-layered sustained release tablets for the first time

2012
-Acquired Pure and Cure Healthcare Private Limited to expand capacity and capabilities

2013
-Innovated tablet-in-tablet sustained release tablets for the first time
-Acquired Malik Lifesciences Private Limited manufacturing sites to expand capacity and capabilities
-Expanded into the African market

2015
-Expanded into the Asian market
-Established research and development laboratory in Mumbai, Maharashtra to venture into regulated market

2016
-Maxcure Nutravedics Limited received US-NSF certification

2019
-Investment by Ruby QC Investment Holdings Pte. Ltd. in our Company to become a minority shareholder

2021
-Acquired Parabolic Drugs to form Akums Lifesciences Limited and ventured into APIs
-Acquisition of a facility at Kotdwar, Uttarakhand by Akums Healthcare Limited

2022
-Plant at 19, 20, 21, Sector 6A, SIDCUL, Haridwar, Uttarakhand and plant at 2, 3, 4,5, Sector 6B, SIDCUL, Haridwar, Uttarakhand accredited European Union-Good Manufacturing Practices, qualifying for exports to European markets
-Acquisition of a facility in Haridwar, Uttarakhand by Akums Healthcare Limited and a facility in Baddi, Himachal Pradesh by Pure and Cure Healthcare Private Limited

2023
-Acquisition of another facility in Baddi, Himachal Pradesh by Pure and Cure Healthcare Private Limited
-Merger of Akums Lifesciences Limited with Pure and Cure Healthcare Private Limited